Unique ID issued by UMIN | UMIN000040044 |
---|---|
Receipt number | R000045653 |
Scientific Title | Effects of switching from Liraglutide to Semaglutide or Dulaglutide in patients with type 2 diabetes:a randomized controlled study |
Date of disclosure of the study information | 2020/05/01 |
Last modified on | 2023/02/24 11:57:14 |
Effects of switching from Liraglutide to Semaglutide or Dulaglutide in patients with type 2 diabetes:a randomized controlled study
Effects of switching from Liraglutide to Semaglutide or Dulaglutide in patients with type 2 diabetes:a randomized controlled study
Effects of switching from Liraglutide to Semaglutide or Dulaglutide in patients with type 2 diabetes:a randomized controlled study
Effects of switching from Liraglutide to Semaglutide or Dulaglutide in patients with type 2 diabetes:a randomized controlled study
Japan |
Type2 diabetes
Endocrinology and Metabolism |
Others
NO
In patients with type 2 diabetes, once-daily liraglutide will be changed to a once-weekly formulation of semaglutide 0.5 mg or duraglutide 0.75 mg and administered for 6 months to compare the efficacy of blood glucose improving effect.
Efficacy
Confirmatory
Explanatory
Not applicable
difference of HbA1c value from baseline 6 months after the start of study
body weight, blood pressure, pulse rate, liver function, renal function, uric acid, urinary microalbumin, C-peptide, complications including diabetic retinopathy, adverse events, DTSQc
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
semaglutide
dulaglutide
20 | years-old | <= |
Not applicable |
Male and Female
(1)Patients who are over 20 years old at registration (regardless of gender)
(2)Patients diagnosed with type 2 diabetes
(3)Patients using liraglutide (0.6mg/0.9mg)
(4)Patients who have not been treated with a new diabetes drug for more than 3 months
(5)Patients who give their consent to participate in this study
(1) Patients with severe liver damage (up to 3 times normal upper limit of AST and ALT within 28 days before registration)
(2) Patients with severe congestive heart failure and acute heart failure
(3) Patients taking steroids
(4) Patients with a history of diabetic ketoacidosis or diabetic coma during the past 6 months
(5) Cancer patients currently undergoing treatment
(6) Patients with severe infections, before and after surgery, with severe trauma
(7) Patients who are contraindicated or allergic to the test drug
(8) Pregnant, possibly pregnant, or wishing to become pregnant during the treatment period and lactating patients
(9) Patients who participated in clinical trials or clinical trials of drugs or medical devices at the same time as this study or within 30 days before enrollment in this study
(10) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor
50
1st name | Terauchi |
Middle name | |
Last name | Yasuo |
Yokohama City University Hospital
Department of Endocrinology & Metabolism
236-0004
3-9 Fukuura, Kanazawa-ku, Yokohama
045-787-2800
terauchi@yokohama-cu.ac.jp
1st name | Iijima |
Middle name | |
Last name | Takahiro |
Yokosuka Kyosai Hospital
Department of Endocrinology & Metabolism
238-8558
1-16 Yonegahamadori, Yokosuka, Kanagawa
046-822-2710
takahiro-iijima@umin.ac.jp
Yokosuka Kyosai Hospital
none
Other
Yokohama City University Hospital
3-9 Fukuura, Kanazawa-ku, Yokohama
045-787-2800
onodera@yokohama-cu.ac.jp
YES
B181004006
Yokohama City University Hospital
2020 | Year | 05 | Month | 01 | Day |
Unpublished
Main results already published
2020 | Year | 03 | Month | 14 | Day |
2020 | Year | 07 | Month | 17 | Day |
2020 | Year | 09 | Month | 01 | Day |
2022 | Year | 11 | Month | 30 | Day |
2022 | Year | 11 | Month | 30 | Day |
2022 | Year | 11 | Month | 30 | Day |
2022 | Year | 11 | Month | 30 | Day |
2020 | Year | 04 | Month | 03 | Day |
2023 | Year | 02 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045653
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |